Matinas BioPharma (MTNB) Earnings Date, Estimates & Call Transcripts → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free MTNB Stock Alerts $0.17 0.00 (0.00%) (As of 05/7/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort Interest Earnings SummaryUpcoming Earnings DateMay. 8EstimatedActual EPS (Mar. 27) -$0.03 Missed By -$0.03 Read Call TranscriptListen to Call Get Matinas BioPharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for MTNB and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueMTNB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MTNB Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. MTNB Earnings Date and InformationMatinas BioPharma last released its quarterly earnings results on March 27th, 2024. The reported ($0.03) earnings per share (EPS) for the quarter. Matinas BioPharma has generated ($0.12) earnings per share over the last year (($0.12) diluted earnings per share). Matinas BioPharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 8th, 2024 based off prior year's report dates.Read More Matinas BioPharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/8/2024Estimated)------- 3/27/2024Q4 2023-($0.03)($0.03)($0.03)-- 11/8/2023Q3 2023-($0.03)($0.03)($0.03)-- 8/9/2023--($0.03)($0.03)($0.03)-- 5/10/2023Q1 2023($0.03)($0.03)-($0.03)$0.30 million$1.10 million3/15/2023Q4 2022($0.02)($0.02)-($0.02)$1.10 million$1.06 million11/2/2022Q3 2022($0.03)($0.03)-($0.03)$1.07 million$1.06 million Get the Latest News and Ratings for MTNB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Matinas BioPharma and its competitors with MarketBeat's FREE daily newsletter. 8/11/2022Q2 2022($0.03)($0.03)-($0.03)$8.20 million$1.06 million 5/12/2022Q1 2022($0.03)($0.03)-($0.03)-- 3/8/2022Q4 2021($0.03)($0.03)-($0.03)-- 11/7/2021Q3 2021($0.02)($0.03)($0.01)($0.03)-- 8/9/2021Q2 2021($0.03)($0.02)+$0.01($0.02)-- 5/10/2021Q1 2021($0.03)($0.03)-($0.03)$0.10 million$0.03 million Matinas BioPharma Earnings - Frequently Asked Questions When is Matinas BioPharma's earnings date? Matinas BioPharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 8th, 2024 based off last year's report dates. Learn more on MTNB's earnings history. How can I listen to Matinas BioPharma's earnings conference call? The conference call for Matinas BioPharma's latest earnings report can be listened to online. Listen to Conference Call How can I read Matinas BioPharma's conference call transcript? The conference call transcript for Matinas BioPharma's latest earnings report can be read online. Read Transcript How much revenue does Matinas BioPharma generate each year? Matinas BioPharma (NYSEAMERICAN:MTNB) has a recorded annual revenue of $1.10 million. How much profit does Matinas BioPharma generate each year? Matinas BioPharma (NYSEAMERICAN:MTNB) has a recorded net income of -$22.94 million. MTNB has generated -$0.12 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Lexaria Bioscience Earnings Date Cara Therapeutics Earnings Date Ocuphire Pharma Earnings Date Unicycive Therapeutics Earnings Date Immuneering Earnings Date Bolt Biotherapeutics Earnings Date Xilio Therapeutics Earnings Date ProMIS Neurosciences Earnings Date Rockwell Medical Earnings Date IGC Pharma Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NYSEAMERICAN:MTNB) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldShocking: One AI startup's revenue could surge 4,735%Manward PressThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorAI “wealth window” is closing June 25thParadigm PressStock-Picking AI Predicts #1 Stock of 2024AltimetryGold Set to EXPLODE!Gold Safe ExchangeThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Matinas BioPharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
